A I Wertheimer
Overview
Explore the profile of A I Wertheimer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
95
Citations
155
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wertheimer A
Curr Med Chem
. 2013 Feb;
20(13):1635-8.
PMID: 23410163
The history of Fixed Dose Combination (FDC) oral drug products has been tumultuous over its history. Some FDCs were prepared for marketing purposes and others for clinical improvements. Often, the...
2.
Altagracia-Martinez M, Kravzov-Jinich J, Guadarrama-Atrizco M, Rubio-Poo C, Wertheimer A
Res Social Adm Pharm
. 2006 Dec;
2(1):22-37.
PMID: 17138499
Background: Little is known about hypertension medication consumption and costs in Mexico. Hypertension control is a pharmacological challenge and a public health issue. Objective: (a) To compare drug sales, number...
3.
Morrison A, Wertheimer A
Am J Health Syst Pharm
. 2001 Apr;
58(7):569-77.
PMID: 11296604
A quantitative evaluation of randomized trials of counseling, education, and other clinical services provided by pharmacists was performed. Data sources were MEDLINE and the bibliographies of published articles. Pharmacists' services...
4.
Guico-Pabia C, Murray J, Teutsch S, Wertheimer A, Berger M
Am J Manag Care
. 2001 Feb;
7(1):27-34.
PMID: 11209448
Background: The management of healthcare programs by employers requires accurate information about the indirect and direct costs of important chronic diseases. Objective: To determine the indirect costs of ischemic heart...
5.
CLAESSON S, Morrison A, Wertheimer A, Berger M
Pharm World Sci
. 2000 Feb;
21(6):256-9.
PMID: 10658233
Compliance with prescribed drug regimens is particularly important among the elderly because of their increased vulnerability and greater burden of chronic disorders. This narrative review discusses the factors that are...
6.
Kong S, Wertheimer A
Am J Manag Care
. 1997 Dec;
4(1):28-34.
PMID: 10179904
Medical and pharmaceutical outcomes research has been of increasing interest in the past 10 to 15 years among healthcare providers, payers, and regulatory agencies. Outcomes research has become a multidisciplinary...
7.
Wertheimer A, Andrews K
Pharmacoeconomics
. 1995 Jan;
7(2):111-8.
PMID: 10155298
No abstract available.
8.
Kong S, Wertheimer A, Serradell J, McGhan W
Pharm Res
. 1994 Jan;
11(1):171-80.
PMID: 8140050
This study utilized different statistical techniques to evaluate the reliability (internal consistency) and the discriminant validity of the most widely used measures of organizational commitment and intention to quit (the...
9.
10.
Habiyambere V, Wertheimer A
World Health Forum
. 1993 Jan;
14(2):140-4.
PMID: 8185754
In Rwanda some 70% of the people do not have regular access to essential drugs and there are chronic drug shortages in government health facilities where drugs are provided free...